5

Pan Drugs

531440 BSE

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

1
  • Company has low interest coverage ratio.

Growth Rate

Revenue Growth
-26%

Quarterly Results

Particulars Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015
Sales
5.39
9.67
8.89
7.44
8.41
12.49
5.52
8.92
6.45
4.15
5.58
Expenses
4.26
9.6
8.48
7.84
8.3
12.28
4.86
9.14
6.2
4.13
5.53
Operating Profit
1.13
0.07
0.41
-0.4
0.11
0.21
0.66
-0.22
0.25
0.02
0.05
OPM %
20.96%
0.72%
4.61%
-5.38%
1.31%
1.68%
11.96%
-2.47%
3.88%
0.48%
0.9%
Other Income
-0.02
0.02
0.2
0.09
0.01
0.02
0.05
0.33
0.04
0.05
0.07
Interest
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0
0.01
0.01
Depreciation
0.14
0.15
0.16
0.15
0.15
0.15
0.2
0.71
0.19
0.19
0.19
PBT
0.96
-0.07
0.44
-0.47
-0.04
0.07
0.5
-0.61
0.1
-0.13
-0.08
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
0.96
-0.06
0.44
-0.47
-0.05
0.07
0.5
-0.61
0.1
-0.13
-0.08
EPS in Rs
3.05
-0.19
1.4
-1.5
-0.16
0.22
1.59
-1.94
0.32
-0.41
-0.25
Figures in ₹ Crores

Profit & Loss

Particulars TTM
Sales
25.1
Expenses
25
Operating Profit
0.1
OPM %
0.4%
Other Income
0.49
Interest
0.03
Depreciation
1.28
PBT
-0.72
Net Profit
-0.72
EPS in Rs
-2.28
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
4
4
4
4
4
4
4
4
5
5
5
5
Reserves
52
43
35
33
40
56
74
93
108
124
137
139
Borrowings
0
0
2
5
5
3
2
1
0
0
0
0
Other Liabilities
14
11
15
12
8
10
21
18
20
23
33
32
Total Liabilities
70
58
56
55
58
74
102
117
133
152
174
177
Fixed Assets
4
3
7
3
3
3
3
3
4
18
19
26
CWIP
0
0
1
2
0
0
6
12
19
5
4
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
66
56
48
50
55
72
93
101
109
129
151
151
Total Assets
70
58
56
55
58
74
102
117
133
152
174
177
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating
-16
-14
12
-13
1
6
11
24
-4
28
2
Investing
1
3
-4
4
-2
0
0
-12
-7
-23
10
Financing
14
4
-2
3
-2
-1
-4
-2
1
-1
-5
Net Cash Flow
0
-7
6
-6
-2
4
8
9
-10
4
7
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
218
222
105
173
187
182
269
194
216
143
164
Cash Conversion Cycle
218
222
105
173
187
182
269
194
216
143
164
Working Capital Days
146
157
42
191
188
212
210
172
221
142
148
ROCE %
—
-15%
-6%
9%
23%
39%
31%
28%
16%
17%
15%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Pan Drugs insights

33 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Shareholding Pattern

Public60.64%Promot.39.36%As ofDec 2017

Y-axis zoomed to the data range so small moves stay visible — it does not start at 0%.

Documents

Frequently Asked Questions about Pan Drugs

Where is Pan Drugs Ltd (531440) listed?
Pan Drugs Ltd trades under code 531440 on the BSE.
Which sector does Pan Drugs Ltd belong to?
Pan Drugs Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Website pandrugsltd.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531440.md for Pan Drugs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List